Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 2,042 | 4,404 | 1,839 | 481 | 352 |
| Cost of Goods | 125 | 267 | 148 | 140 | N/A |
| Gross Profit | 1,917 | 4,137 | 1,691 | 341 | 352 |
| Operating Expenses | 5,846 | 8,720 | 9,715 | 8,238 | 10,028 |
| Operating Income | -3,804 | -4,316 | -7,876 | -7,757 | -9,676 |
| Interest Expense | 279 | 608 | 0 | 607 | 539 |
| Other Income | 8,532 | -5,608 | 5,361 | 827 | -7,125 |
| Pre-tax Income | 4,449 | -10,532 | -2,515 | -7,537 | -17,340 |
| Income Tax | N/A | N/A | 17 | N/A | N/A |
| Net Income Continuous | 4,449 | -10,532 | -2,532 | -7,537 | -17,340 |
| Net Income | $4,449 | $-10,532 | $-2,532 | $-7,537 | $-17,340 |
| EPS Basic Total Ops | 76.75 | -650.00 | -275.00 | -750.00 | -2,037.50 |
| EPS Basic Continuous Ops | 220.31 | -544.49 | -158.38 | -602.65 | -1,833.91 |
| EPS Diluted Total Ops | 76.00 | -650.00 | -275.00 | -750.00 | -2,037.50 |
| EPS Diluted Continuous Ops | 218.31 | -544.49 | -158.38 | -602.65 | -1,833.91 |
| EBITDA(a) | $-3,801 | $-3,897 | $-7,643 | $-7,519 | $-9,417 |